Embolization Particle Market - Global Forecast 2026-2032

The embolization particle market is rapidly evolving, driven by the convergence of clinical needs, technological innovation, and shifting regulatory and commercial environments. Senior decision-makers require a strategic, actionable view of growth dynamics, risks, and opportunities that shape competitive positioning in this sector.

Market Snapshot: Embolization Particle Market Size & Growth

The embolization particle market grew from USD 2.00 billion in 2025 to USD 2.23 billion in 2026. It is projected to sustain a CAGR of 12.82%, reaching USD 4.65 billion by 2032. This performance is underpinned by expanding use of image-guided, minimally invasive therapeutic procedures, strong innovation in biomaterials, and increasing adoption in oncology and vascular interventions.

Scope & Segmentation

This report provides a comprehensive analysis across core dimensions shaping the embolization particle competitive landscape:

Product Types: Gelatin Sponge Particles, Liquid Embolic Systems, Microspheres, Polyvinyl Alcohol Particles
Application Areas: Hepatic Oncology, Neurovascular Procedures, Peripheral Arterial Embolization, Prostate Artery Embolization, Uterine Fibroid Embolization
End-User Environments: Ambulatory Surgical Centers, Hospitals, Specialty Clinics
Embolic Material Subclasses: Natural Materials (Collagen, Gelatin), Synthetic Materials (Acrylic Polymers, Polyvinyl Alcohol)
Mode of Action: Permanent vs. Temporary occlusion
Geographic Regions: Americas, Europe, Middle East & Africa, Asia-Pacific

Segmentation analysis highlights the alignment between technical attributes, procurement patterns, and clinical and operational priorities. Regional differentiation is critical as access pathways, regulatory environments, and local clinical leadership shape adoption strategies.

Key Takeaways: Strategic Insights for Decision-Makers

Advanced biomaterials and image-guided delivery platforms are redefining procedural safety and expanding the scope of embolization therapies in clinical practice.
Procurement and hospital systems increasingly value predictable supply, post-market support, and real-world evidence demonstrating comparative effectiveness.
Regulatory scrutiny around device biocompatibility, traceability, and surveillance now strongly influences new product launches and time to market.
Supply chain resilience and regionalized manufacturing have emerged as strategic imperatives following recent global disruptions, altering sourcing and vendor qualification processes.
Competitive advantage is shifting from technical product features to end-to-end support, encompassing evidence generation and tailored service models across diverse care settings.

Tariff Impact on Market Dynamics

Recent United States tariff measures are impacting supply chains, manufacturing costs, and procurement strategies for embolization particle manufacturers and distributors. Fluctuating duties on raw materials and finished medical products have prompted firms to reconsider sourcing locations, pursue regional manufacturing strategies, and secure long-term agreements to mitigate cost variability and ensure supply continuity. Procurement leaders in healthcare are placing additional emphasis on supplier stability, contractual protections, and risk-sharing measures in response to these external pressures.

Primary Keyword Focus: Embolization Particle Market

This report evaluates how clinical innovation, biomaterials progress, and operational resilience are jointly redefining the embolization particle market's competitive edge. It addresses adoption patterns in key global regions and dissects the interplay of clinical, regulatory, and commercial drivers influencing stakeholder priorities.

Methodology & Data Sources

Analysis integrates peer-reviewed scientific literature, regulatory filings, clinical registry data, and structured interviews with clinicians, supply chain managers, and device executives. Supplementary insights stem from industry publications, tariff records, and materials science reviews, creating a validated multi-source foundation for the findings. Data triangulation ensures consensus-based perspectives and reduces bias.

Why This Report Matters

Identify actionable growth opportunities by segment, technology, and region.
Align operational, clinical, and sourcing strategies to new market realities and regulatory demands.
Leverage competitive intelligence to inform investment, product development, and go-to-market planning.

Conclusion

The embolization particle industry is at a pivotal point where clinical trust, resilient operations, and evidence-driven strategies will define sustained success. Decision-makers equipped with comprehensive, actionable insights can position their organizations to capture long-term value in this evolving landscape.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Embolization Particle Market, by Product Type

8.1. Gelatin Sponge Particles
8.2. Liquid Embolic Systems
8.3. Microspheres
8.4. Polyvinyl Alcohol Particles

9. Embolization Particle Market, by Embolic Material

9.1. Natural Materials
9.1.1. Collagen
9.1.2. Gelatin
9.2. Synthetic Materials
9.2.1. Acrylic Polymers
9.2.2. Polyvinyl Alcohol

10. Embolization Particle Market, by Mode Of Action

10.1. Permanent
10.2. Temporary

11. Embolization Particle Market, by Application

11.1. Hepatic Oncology
11.2. Neurovascular Procedures
11.3. Peripheral Arterial Embolization
11.4. Prostate Artery Embolization
11.5. Uterine Fibroid Embolization

12. Embolization Particle Market, by End Use

12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Specialty Clinics

13. Embolization Particle Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Embolization Particle Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Embolization Particle Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Embolization Particle Market
17. China Embolization Particle Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AngioDynamics, Inc.
18.6. Boston Scientific Corporation
18.7. Guerbet Group SA
18.8. INterface BIOmaterials B.V.
18.9. Kaneka Corporation
18.10. Merit Medical Systems, Inc.
18.11. Penumbra, Inc.
18.12. Sirtex Medical Limited
18.13. Terumo Corporation

List of Figures

FIGURE 1. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA EMBOLIZATION PARTICLE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 105. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 106. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 118. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 121. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 122. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 123. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 124. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 138. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 139. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 140. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 141. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. ASEAN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 143. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 146. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 147. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 148. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 149. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. GCC EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 159. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 162. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 163. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 164. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 165. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. BRICS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 167. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 170. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 171. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 172. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 173. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. G7 EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 175. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 178. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 179. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 180. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 181. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. NATO EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 192. CHINA EMBOLIZATION PARTICLE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2032 (USD MILLION)
TABLE 195. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 196. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
TABLE 197. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
TABLE 198. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)

Companies Mentioned

AngioDynamics, Inc.
Boston Scientific Corporation
Guerbet Group SA
INterface BIOmaterials B.V.
Kaneka Corporation
Merit Medical Systems, Inc.
Penumbra, Inc.
Sirtex Medical Limited
Terumo Corporation

Table Information

Report Attribute	Details
No. of Pages	193
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.23 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.65 Billion
Compound Annual Growth Rate	12.8%
Regions Covered	Global
No. of Companies Mentioned	9

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Embolization Particle Market Size & Growth

Scope & Segmentation

Key Takeaways: Strategic Insights for Decision-Makers

Tariff Impact on Market Dynamics

Primary Keyword Focus: Embolization Particle Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Vascular Embolization Market - Global Forecast 2025-2032

Embolization Product Market Report: Trends, Forecast and Competitive Analysis to 2031

Vascular Embolization Market Report 2025

Embolization Particles Market Size By Segments, Share, Regulatory, Reimbursement, Interventions And Forecast To 2036

Embolization Coils Market - Global Strategic Business Report